This mouse monoclonal antibody for KSHV (tegument) protein open reading frame 33 (ORF 33) was generated using a bacterially produced recombinant protein as an antigen.
| Inventor | Institute |
|---|---|
| Fanxiu Zhu | Florida State University Research Foundation |
| SKU: | 160638 |
|---|---|
| Product description: | Kaposi’s sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi’s sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015). This mouse monoclonal antibody for KSHV (tegument) protein open reading frame 33 (ORF 33) was generated using a bacterially produced recombinant protein as an antigen. ORF33 has been shown to be a crucial component of progeny virion production in conjunction with ORF45. ORF33 binding domain has been mapped to the highly conserved carboxyl-terminal 19 aa of ORF 45 and to USP7 binding domain according to Gillen et al., 2015. ORF33 has also been shown to interact with ORF38. |
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Immunogen: | A bacterially produced recombinant ORF 33 protein was used as an antigen |
| Cat. #: | 160638 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Genetics;Microbiology |
| Application: | WB |
| Target: | Open Reading Frame 33 |
| Reactivity: | Other Species |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Kaposi’s sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi’s sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015). This mouse monoclonal antibody for KSHV (tegument) protein open reading frame 33 (ORF 33) was generated using a bacterially produced recombinant protein as an antigen. ORF33 has been shown to be a crucial component of progeny virion production in conjunction with ORF45. ORF33 binding domain has been mapped to the highly conserved carboxyl-terminal 19 aa of ORF 45 and to USP7 binding domain according to Gillen et al., 2015. ORF33 has also been shown to interact with ORF38. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Wu et al. 2016. J Virol. 90(4):1741-56. PMID: 26637455. Gillen et al. 2015. J Virol. 89(9):4918-31. PMID: 25694600. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.